Navigation Links
Bacterin International Introduces OsteoSelect(R) DBM Putty
Date:3/10/2010

BELGRADE, Mont., March 10 /PRNewswire/ -- Bacterin International, Inc. (Bacterin), a biologic company focused on the development of innovative, specialty allografts, announces the introduction of OsteoSelect® DBM Putty for orthopedic bone grafting applications.  OsteoSelect® is a moldable allograft designed to withstand irrigation while exhibiting osteoinductive properties for improved bone regeneration.  OsteoSelect® will be an ideal complement to Bacterin's current product portfolio, which focuses on optimizing handling characteristics and biologic performance of grafting materials for surgeons.

"The development and release of Bacterin's first allograft based medical device represents another significant milestone in the evolution of Bacterin's Biologics Division," said Gregory Juda, PhD, Senior Biologics Scientist for Bacterin and product manager of OsteoSelect® DBM Putty.  Dr. Juda continued to say, "Bacterin used considerable input from the surgical community during the design of OsteoSelect® DBM Putty and thus far, the feedback from
'/>"/>

SOURCE Bacterin International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bacterin International Completes $3 Million Private Placement
2. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
3. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
4. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
5. International Merchant Advisors Reaches Agreement in Principal to Acquire First Medical Marijuana Clinic Operations
6. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
7. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
8. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
9. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
10. Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International
11. International Merchant Advisors, Inc. Signs LOI to Invest in Pharmaceutical Chain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Southfield Capital, a ... announced today that it completed a dividend ... specializes in the development and multi-channel deployment ... and biotechnology industries. Through the ... half of their invested capital and secured ...
(Date:5/4/2015)... RadiologyAuction will have their first auction starting May ... at the end of the auction on May 27 ... Fuji Cr,s, Agfa and Sony, printers and GE portable ... imaging equipment will be available at later auctions each ... of buying and selling imaging equipment, the brokers at ...
(Date:5/4/2015)... VALLEY, Calif. , May 4, 2015 ... biologic for psoriasis, today announced that preclinical and mechanism ... session at the Society of Investigative Dermatology (SID) Annual ... Atlanta, in Atlanta, Georgia . ... is advancing the development of RON2315, a novel, low ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2RadiologyAuction Announces Event Starting On May 5th 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
... 25, 2007 - Reata,Pharmaceuticals, Inc. today announced ... company's Synthetic Triterpenoid programs in,the May 2007 ... The article, "Triterpenoids and rexinoids as multifunctional,agents ... by researchers,and Reata scientific collaborators from the ...
... - Introgen,Therapeutics, Inc. (NASDAQ:INGN) today announced the publication ... survival,pathway impacts the anticancer activity of INGN 241. ... tumor killing effects of,INGN 241 in cell culture ... Introgen and The University of Texas M. D. ...
Cached Medicine Technology:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 2Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 3
(Date:5/4/2015)... In a continuing effort to remain ... Per Wickstrom, the founder of Choices Recovery in South ... “Salute to the Oscars” celebration held on February ... floor of the luxurious Beverly Hilton Hotel. , ... sustainable product placement in TV and film, this daylong ...
(Date:5/4/2015)... York (PRWEB) May 04, 2015 Takeda ... $2.4 billion to settle thousands of Actos lawsuits ( ... medication increases the risk that a patient will develop ... April 28th, if 95% of those eligible for the ... nearly 9,000 bladder cancer cases currently pending in courts ...
(Date:5/4/2015)... SAN DIEGO, California (PRWEB) May 04, 2015 ... health plans to manage their health is critical to ... patient satisfaction and reducing costs, but this will require ... spectrum. This change also demands that health systems move ... to speakers who took part in the third live ...
(Date:5/4/2015)... 2015 TROY Healthcare Solutions is proud ... Regional User Group (RUG) Conference in Baltimore, MD from ... Regional User Group provides an opportunity for clients to ... exhibitor gallery. , In addition to sponsoring the event, ... North Atlantic RUG Conference. Attendees can stop by the ...
(Date:5/4/2015)... 04, 2015 The opportunity for children to ... are the motivating forces behind The Fairy Godmother Next Door, ... author Amy L. Stark. , The inspiration for the enchanting ... door comes from Stark’s desire to be a fairy godmother. ... fairy godmother to my neighbors’ children since they were born. ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2
... Initiative (WHI) report show that hormone therapy is associated with ... well as an increased risk of developing invasive breast cancer ... and preventive medicine at the University at Buffalo and one ... JAMA , says the breast cancers found in these ...
... a little-known variety of the grain that is the ... help soothe the inflammation involved in allergies, asthma, and other ... Agricultural and Food Chemistry . Mendel Friedman and colleagues ... benefits of eating black rice bran. Bran is the outer ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) ... (CML) who decided to stop taking the cancer drug Gleevec ... The study, published online Oct. 19 in The ... that the drug might go beyond long-term cancer control and ...
... Jordan, 20 October 2010 Elsevier Middle East announces ... ( JIPH ) has been selected for inclusion in MEDLINE, ... Medicine (NLM). Citations for articles indexed, the indexing terms and ... PubMed ( www.pubmed.gov ). Indexing using the US National Library ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) -- Not only ... breast cancer, new research finds, but it also ups the risk ... chances of dying. A study appearing in the Oct. 20 ... is at odds with previous observational studies that had suggested a ...
... TUESDAY, Oct. 19 (HealthDay News) -- Heavy alcohol and marijuana ... persist into adulthood, according to a new study. The ... scored lower than their abstinent peers on tests measuring a ... professor of psychiatry at the University of New Mexico School ...
Cached Medicine News:Health News:Hormone therapy increases invasive breast cancer and mortality, WHI 11-year follow up finds 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 3Health News:Study Shows HRT Even Riskier Than Thought 2Health News:Study Shows HRT Even Riskier Than Thought 3Health News:Binge Drinking, Pot Could Put Teens' Intellect at Risk: Study 2Health News:Binge Drinking, Pot Could Put Teens' Intellect at Risk: Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: